The University of Chicago Header Logo

Connection

Kerstin Stenson to Erlotinib Hydrochloride

Back to Details
This is a "connection" page, showing publications Kerstin Stenson has written about Erlotinib Hydrochloride.
Kerstin Stenson
Connection Strength
0.020
Erlotinib Hydrochloride
  1. Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study. Lancet Oncol. 2009 Mar; 10(3):247-57.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.